nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—SIGMAR1—amyotrophic lateral sclerosis	0.468	1	CbGaD
Tamoxifen—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.153	0.428	CbGbCtD
Tamoxifen—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.141	0.395	CbGbCtD
Tamoxifen—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.0632	0.177	CbGbCtD
Tamoxifen—Uterine leiomyoma—Riluzole—amyotrophic lateral sclerosis	0.00465	0.0508	CcSEcCtD
Tamoxifen—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00251	0.0274	CcSEcCtD
Tamoxifen—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0252	CcSEcCtD
Tamoxifen—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0236	CcSEcCtD
Tamoxifen—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0223	CcSEcCtD
Tamoxifen—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0218	CcSEcCtD
Tamoxifen—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0206	CcSEcCtD
Tamoxifen—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0202	CcSEcCtD
Tamoxifen—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0198	CcSEcCtD
Tamoxifen—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0191	CcSEcCtD
Tamoxifen—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0187	CcSEcCtD
Tamoxifen—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0187	CcSEcCtD
Tamoxifen—Naftifine—SIGMAR1—amyotrophic lateral sclerosis	0.00154	0.603	CrCbGaD
Tamoxifen—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0165	CcSEcCtD
Tamoxifen—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0158	CcSEcCtD
Tamoxifen—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0152	CcSEcCtD
Tamoxifen—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0151	CcSEcCtD
Tamoxifen—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00137	0.015	CcSEcCtD
Tamoxifen—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0146	CcSEcCtD
Tamoxifen—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0145	CcSEcCtD
Tamoxifen—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00128	0.014	CcSEcCtD
Tamoxifen—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.014	CcSEcCtD
Tamoxifen—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0139	CcSEcCtD
Tamoxifen—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00124	0.0136	CcSEcCtD
Tamoxifen—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0133	CcSEcCtD
Tamoxifen—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0133	CcSEcCtD
Tamoxifen—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0128	CcSEcCtD
Tamoxifen—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0126	CcSEcCtD
Tamoxifen—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0122	CcSEcCtD
Tamoxifen—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0011	0.012	CcSEcCtD
Tamoxifen—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0115	CcSEcCtD
Tamoxifen—Clomifene—SIGMAR1—amyotrophic lateral sclerosis	0.00101	0.397	CrCbGaD
Tamoxifen—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00101	0.011	CcSEcCtD
Tamoxifen—Injury—Riluzole—amyotrophic lateral sclerosis	0.000958	0.0105	CcSEcCtD
Tamoxifen—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000925	0.0101	CcSEcCtD
Tamoxifen—ESR2—hindbrain—amyotrophic lateral sclerosis	0.000921	0.0346	CbGeAlD
Tamoxifen—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000906	0.0099	CcSEcCtD
Tamoxifen—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000881	0.00962	CcSEcCtD
Tamoxifen—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00911	CcSEcCtD
Tamoxifen—EBPL—nervous system—amyotrophic lateral sclerosis	0.000828	0.0312	CbGeAlD
Tamoxifen—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000813	0.00888	CcSEcCtD
Tamoxifen—EBPL—central nervous system—amyotrophic lateral sclerosis	0.000797	0.03	CbGeAlD
Tamoxifen—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00866	CcSEcCtD
Tamoxifen—SULT1A1—spinal cord—amyotrophic lateral sclerosis	0.000781	0.0294	CbGeAlD
Tamoxifen—EBPL—cerebellum—amyotrophic lateral sclerosis	0.000779	0.0293	CbGeAlD
Tamoxifen—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000777	0.00849	CcSEcCtD
Tamoxifen—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000761	0.00832	CcSEcCtD
Tamoxifen—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000761	0.00832	CcSEcCtD
Tamoxifen—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000746	0.00815	CcSEcCtD
Tamoxifen—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000741	0.0081	CcSEcCtD
Tamoxifen—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000732	0.008	CcSEcCtD
Tamoxifen—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00797	CcSEcCtD
Tamoxifen—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000723	0.0079	CcSEcCtD
Tamoxifen—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000712	0.00778	CcSEcCtD
Tamoxifen—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000701	0.00766	CcSEcCtD
Tamoxifen—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000693	0.00757	CcSEcCtD
Tamoxifen—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000688	0.00752	CcSEcCtD
Tamoxifen—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000682	0.00746	CcSEcCtD
Tamoxifen—Depression—Riluzole—amyotrophic lateral sclerosis	0.000677	0.00739	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000669	0.00731	CcSEcCtD
Tamoxifen—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000665	0.00727	CcSEcCtD
Tamoxifen—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00721	CcSEcCtD
Tamoxifen—SULT1A1—nervous system—amyotrophic lateral sclerosis	0.000658	0.0247	CbGeAlD
Tamoxifen—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000651	0.00711	CcSEcCtD
Tamoxifen—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000637	0.00696	CcSEcCtD
Tamoxifen—SULT1A1—central nervous system—amyotrophic lateral sclerosis	0.000634	0.0238	CbGeAlD
Tamoxifen—EBPL—brain—amyotrophic lateral sclerosis	0.000633	0.0238	CbGeAlD
Tamoxifen—ESR1—hindbrain—amyotrophic lateral sclerosis	0.000631	0.0237	CbGeAlD
Tamoxifen—DHCR7—medulla oblongata—amyotrophic lateral sclerosis	0.000623	0.0234	CbGeAlD
Tamoxifen—SULT1A1—cerebellum—amyotrophic lateral sclerosis	0.000619	0.0233	CbGeAlD
Tamoxifen—ESRRA—medulla oblongata—amyotrophic lateral sclerosis	0.000613	0.0231	CbGeAlD
Tamoxifen—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000612	0.00669	CcSEcCtD
Tamoxifen—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000609	0.00666	CcSEcCtD
Tamoxifen—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000609	0.00666	CcSEcCtD
Tamoxifen—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000606	0.00662	CcSEcCtD
Tamoxifen—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000605	0.00661	CcSEcCtD
Tamoxifen—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0006	0.00656	CcSEcCtD
Tamoxifen—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00629	CcSEcCtD
Tamoxifen—DHCR7—spinal cord—amyotrophic lateral sclerosis	0.000555	0.0209	CbGeAlD
Tamoxifen—ESRRA—spinal cord—amyotrophic lateral sclerosis	0.000547	0.0206	CbGeAlD
Tamoxifen—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000544	0.00595	CcSEcCtD
Tamoxifen—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00588	CcSEcCtD
Tamoxifen—ESR2—brainstem—amyotrophic lateral sclerosis	0.000528	0.0198	CbGeAlD
Tamoxifen—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000519	0.00567	CcSEcCtD
Tamoxifen—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000513	0.0056	CcSEcCtD
Tamoxifen—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00051	0.00557	CcSEcCtD
Tamoxifen—SULT1A1—brain—amyotrophic lateral sclerosis	0.000503	0.0189	CbGeAlD
Tamoxifen—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00049	0.00536	CcSEcCtD
Tamoxifen—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000485	0.00529	CcSEcCtD
Tamoxifen—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000475	0.00519	CcSEcCtD
Tamoxifen—DHCR7—nervous system—amyotrophic lateral sclerosis	0.000468	0.0176	CbGeAlD
Tamoxifen—FMO1—nervous system—amyotrophic lateral sclerosis	0.000468	0.0176	CbGeAlD
Tamoxifen—Cough—Riluzole—amyotrophic lateral sclerosis	0.000463	0.00506	CcSEcCtD
Tamoxifen—ESRRA—nervous system—amyotrophic lateral sclerosis	0.000461	0.0173	CbGeAlD
Tamoxifen—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000458	0.005	CcSEcCtD
Tamoxifen—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00493	CcSEcCtD
Tamoxifen—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00493	CcSEcCtD
Tamoxifen—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00493	CcSEcCtD
Tamoxifen—DHCR7—central nervous system—amyotrophic lateral sclerosis	0.000451	0.0169	CbGeAlD
Tamoxifen—FMO1—central nervous system—amyotrophic lateral sclerosis	0.000451	0.0169	CbGeAlD
Tamoxifen—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00045	0.00492	CcSEcCtD
Tamoxifen—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000446	0.00487	CcSEcCtD
Tamoxifen—ESRRA—central nervous system—amyotrophic lateral sclerosis	0.000444	0.0167	CbGeAlD
Tamoxifen—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00482	CcSEcCtD
Tamoxifen—DHCR7—cerebellum—amyotrophic lateral sclerosis	0.00044	0.0166	CbGeAlD
Tamoxifen—ESRRA—cerebellum—amyotrophic lateral sclerosis	0.000434	0.0163	CbGeAlD
Tamoxifen—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000433	0.00473	CcSEcCtD
Tamoxifen—Infection—Riluzole—amyotrophic lateral sclerosis	0.00043	0.0047	CcSEcCtD
Tamoxifen—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000424	0.00463	CcSEcCtD
Tamoxifen—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000418	0.00457	CcSEcCtD
Tamoxifen—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000413	0.00451	CcSEcCtD
Tamoxifen—FMO3—nervous system—amyotrophic lateral sclerosis	0.000405	0.0152	CbGeAlD
Tamoxifen—ESR1—embryo—amyotrophic lateral sclerosis	0.000394	0.0148	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000394	0.00431	CcSEcCtD
Tamoxifen—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00428	CcSEcCtD
Tamoxifen—FMO3—central nervous system—amyotrophic lateral sclerosis	0.000389	0.0146	CbGeAlD
Tamoxifen—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000389	0.00425	CcSEcCtD
Tamoxifen—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00422	CcSEcCtD
Tamoxifen—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000381	0.00416	CcSEcCtD
Tamoxifen—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000376	0.00411	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00408	CcSEcCtD
Tamoxifen—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000373	0.00408	CcSEcCtD
Tamoxifen—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00037	0.00404	CcSEcCtD
Tamoxifen—Pain—Riluzole—amyotrophic lateral sclerosis	0.00037	0.00404	CcSEcCtD
Tamoxifen—ESR1—brainstem—amyotrophic lateral sclerosis	0.000361	0.0136	CbGeAlD
Tamoxifen—DHCR7—brain—amyotrophic lateral sclerosis	0.000358	0.0135	CbGeAlD
Tamoxifen—FMO1—brain—amyotrophic lateral sclerosis	0.000358	0.0135	CbGeAlD
Tamoxifen—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00387	CcSEcCtD
Tamoxifen—ESRRA—brain—amyotrophic lateral sclerosis	0.000352	0.0132	CbGeAlD
Tamoxifen—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000346	0.013	CbGeAlD
Tamoxifen—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000344	0.00376	CcSEcCtD
Tamoxifen—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000342	0.00374	CcSEcCtD
Tamoxifen—CES1—nervous system—amyotrophic lateral sclerosis	0.000319	0.012	CbGeAlD
Tamoxifen—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000319	0.00348	CcSEcCtD
Tamoxifen—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00339	CcSEcCtD
Tamoxifen—FMO3—brain—amyotrophic lateral sclerosis	0.000309	0.0116	CbGeAlD
Tamoxifen—CES1—central nervous system—amyotrophic lateral sclerosis	0.000307	0.0116	CbGeAlD
Tamoxifen—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000306	0.00335	CcSEcCtD
Tamoxifen—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00324	CcSEcCtD
Tamoxifen—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000286	0.00313	CcSEcCtD
Tamoxifen—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	0.000285	0.0107	CbGeAlD
Tamoxifen—ESR2—nervous system—amyotrophic lateral sclerosis	0.000277	0.0104	CbGeAlD
Tamoxifen—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000275	0.00301	CcSEcCtD
Tamoxifen—Rash—Riluzole—amyotrophic lateral sclerosis	0.000273	0.00298	CcSEcCtD
Tamoxifen—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000273	0.00298	CcSEcCtD
Tamoxifen—Headache—Riluzole—amyotrophic lateral sclerosis	0.000271	0.00296	CcSEcCtD
Tamoxifen—ESR2—central nervous system—amyotrophic lateral sclerosis	0.000266	0.01	CbGeAlD
Tamoxifen—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000262	0.00984	CbGeAlD
Tamoxifen—ESR2—cerebellum—amyotrophic lateral sclerosis	0.00026	0.00979	CbGeAlD
Tamoxifen—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000257	0.00281	CcSEcCtD
Tamoxifen—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	0.000254	0.00956	CbGeAlD
Tamoxifen—CES1—brain—amyotrophic lateral sclerosis	0.000244	0.00918	CbGeAlD
Tamoxifen—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.000218	0.0082	CbGeAlD
Tamoxifen—CYP2A6—brain—amyotrophic lateral sclerosis	0.000212	0.00799	CbGeAlD
Tamoxifen—ESR2—brain—amyotrophic lateral sclerosis	0.000211	0.00795	CbGeAlD
Tamoxifen—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.00021	0.00789	CbGeAlD
Tamoxifen—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.000204	0.00766	CbGeAlD
Tamoxifen—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000202	0.00759	CbGeAlD
Tamoxifen—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	0.000202	0.00758	CbGeAlD
Tamoxifen—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000198	0.00746	CbGeAlD
Tamoxifen—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000196	0.00738	CbGeAlD
Tamoxifen—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.000192	0.00721	CbGeAlD
Tamoxifen—ESR1—nervous system—amyotrophic lateral sclerosis	0.000189	0.00712	CbGeAlD
Tamoxifen—ESR1—central nervous system—amyotrophic lateral sclerosis	0.000182	0.00686	CbGeAlD
Tamoxifen—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.00018	0.00677	CbGeAlD
Tamoxifen—ESR1—cerebellum—amyotrophic lateral sclerosis	0.000178	0.0067	CbGeAlD
Tamoxifen—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000175	0.00657	CbGeAlD
Tamoxifen—CYP19A1—brain—amyotrophic lateral sclerosis	0.000167	0.00626	CbGeAlD
Tamoxifen—SIGMAR1—brain—amyotrophic lateral sclerosis	0.000164	0.00616	CbGeAlD
Tamoxifen—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000156	0.00586	CbGeAlD
Tamoxifen—ABCB1—embryo—amyotrophic lateral sclerosis	0.000156	0.00586	CbGeAlD
Tamoxifen—CYP1B1—brain—amyotrophic lateral sclerosis	0.000156	0.00586	CbGeAlD
Tamoxifen—ESR1—brain—amyotrophic lateral sclerosis	0.000145	0.00544	CbGeAlD
Tamoxifen—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000144	0.00542	CbGeAlD
Tamoxifen—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000143	0.00537	CbGeAlD
Tamoxifen—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.00014	0.00526	CbGeAlD
Tamoxifen—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000139	0.00521	CbGeAlD
Tamoxifen—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000135	0.00507	CbGeAlD
Tamoxifen—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000131	0.00494	CbGeAlD
Tamoxifen—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000126	0.00476	CbGeAlD
Tamoxifen—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000124	0.00465	CbGeAlD
Tamoxifen—CYP2C8—brain—amyotrophic lateral sclerosis	0.000119	0.00448	CbGeAlD
Tamoxifen—ABCG2—brain—amyotrophic lateral sclerosis	0.000116	0.00436	CbGeAlD
Tamoxifen—CYP1A1—brain—amyotrophic lateral sclerosis	0.00011	0.00414	CbGeAlD
Tamoxifen—CYP2B6—brain—amyotrophic lateral sclerosis	0.000107	0.00402	CbGeAlD
Tamoxifen—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000106	0.00397	CbGeAlD
Tamoxifen—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000104	0.00391	CbGeAlD
Tamoxifen—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000102	0.00383	CbGeAlD
Tamoxifen—CYP2E1—brain—amyotrophic lateral sclerosis	0.0001	0.00378	CbGeAlD
Tamoxifen—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.0001	0.00377	CbGeAlD
Tamoxifen—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	9.96e-05	0.00374	CbGeAlD
Tamoxifen—CYP2D6—cerebellum—amyotrophic lateral sclerosis	9.79e-05	0.00368	CbGeAlD
Tamoxifen—ABCB1—spinal cord—amyotrophic lateral sclerosis	8.88e-05	0.00334	CbGeAlD
Tamoxifen—CYP2D6—brain—amyotrophic lateral sclerosis	7.95e-05	0.00299	CbGeAlD
Tamoxifen—ABCB1—nervous system—amyotrophic lateral sclerosis	7.48e-05	0.00281	CbGeAlD
Tamoxifen—ABCB1—central nervous system—amyotrophic lateral sclerosis	7.2e-05	0.00271	CbGeAlD
Tamoxifen—ABCB1—cerebellum—amyotrophic lateral sclerosis	7.04e-05	0.00265	CbGeAlD
Tamoxifen—ABCB1—brain—amyotrophic lateral sclerosis	5.72e-05	0.00215	CbGeAlD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	1.98e-05	0.000372	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.98e-05	0.000372	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.95e-05	0.000367	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.95e-05	0.000366	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.93e-05	0.000363	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.93e-05	0.000362	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.91e-05	0.000358	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.89e-05	0.000354	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.88e-05	0.000352	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.85e-05	0.000347	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—APOE—amyotrophic lateral sclerosis	1.85e-05	0.000347	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.85e-05	0.000347	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.84e-05	0.000346	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.84e-05	0.000345	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.84e-05	0.000344	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	1.83e-05	0.000344	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	1.82e-05	0.000341	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.81e-05	0.000338	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.8e-05	0.000338	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GSR—amyotrophic lateral sclerosis	1.78e-05	0.000334	CbGpPWpGaD
Tamoxifen—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.78e-05	0.000334	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.77e-05	0.000333	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.77e-05	0.000333	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.75e-05	0.000329	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.75e-05	0.000328	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	1.74e-05	0.000326	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.73e-05	0.000325	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.73e-05	0.000325	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.73e-05	0.000325	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—APOE—amyotrophic lateral sclerosis	1.72e-05	0.000323	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.72e-05	0.000322	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.7e-05	0.000319	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	1.7e-05	0.000318	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.69e-05	0.000317	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.68e-05	0.000316	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	1.66e-05	0.000312	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.66e-05	0.000311	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.65e-05	0.00031	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.63e-05	0.000306	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.63e-05	0.000306	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.63e-05	0.000306	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.62e-05	0.000304	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000304	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.62e-05	0.000304	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.62e-05	0.000303	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.62e-05	0.000303	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.61e-05	0.000302	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	1.6e-05	0.000301	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.6e-05	0.0003	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.59e-05	0.000299	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.59e-05	0.000298	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.58e-05	0.000297	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.57e-05	0.000294	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.56e-05	0.000292	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.53e-05	0.000288	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.53e-05	0.000288	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.53e-05	0.000286	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.52e-05	0.000285	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.51e-05	0.000283	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.51e-05	0.000283	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.5e-05	0.000281	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.49e-05	0.00028	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.48e-05	0.000277	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.47e-05	0.000277	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.47e-05	0.000276	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	1.47e-05	0.000276	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.47e-05	0.000275	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.46e-05	0.000274	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.46e-05	0.000274	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.44e-05	0.000269	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.42e-05	0.000266	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.41e-05	0.000264	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.39e-05	0.000261	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.39e-05	0.00026	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.38e-05	0.00026	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.38e-05	0.00026	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.38e-05	0.000259	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.38e-05	0.000259	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.38e-05	0.000258	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.37e-05	0.000257	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.37e-05	0.000257	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.35e-05	0.000253	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.34e-05	0.000251	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.33e-05	0.00025	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.33e-05	0.000249	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000248	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	1.32e-05	0.000247	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.3e-05	0.000245	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.3e-05	0.000243	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.29e-05	0.000243	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.29e-05	0.000242	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.29e-05	0.000242	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.29e-05	0.000241	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.28e-05	0.00024	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.27e-05	0.000238	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.26e-05	0.000237	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.26e-05	0.000236	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.26e-05	0.000236	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.26e-05	0.000236	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.25e-05	0.000235	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.21e-05	0.000227	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.21e-05	0.000227	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.19e-05	0.000223	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.19e-05	0.000223	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.18e-05	0.000221	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.18e-05	0.000221	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.18e-05	0.00022	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.17e-05	0.000219	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.16e-05	0.000218	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.16e-05	0.000218	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.15e-05	0.000215	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.14e-05	0.000213	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.11e-05	0.000208	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.1e-05	0.000207	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.1e-05	0.000206	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.09e-05	0.000204	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.08e-05	0.000203	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.08e-05	0.000202	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.07e-05	0.0002	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.07e-05	0.0002	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1e-05	0.000188	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	9.99e-06	0.000187	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.99e-06	0.000187	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.98e-06	0.000187	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.93e-06	0.000186	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	9.75e-06	0.000183	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	9.75e-06	0.000183	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	9.72e-06	0.000182	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.55e-06	0.000179	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	9.53e-06	0.000179	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.49e-06	0.000178	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.49e-06	0.000178	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.15e-06	0.000172	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.14e-06	0.000171	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.07e-06	0.00017	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.07e-06	0.00017	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	9e-06	0.000169	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	8.97e-06	0.000168	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	8.94e-06	0.000168	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	8.86e-06	0.000166	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	8.75e-06	0.000164	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	8.53e-06	0.00016	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.48e-06	0.000159	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	8.25e-06	0.000155	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	8.25e-06	0.000155	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.21e-06	0.000154	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	8.18e-06	0.000153	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—APOE—amyotrophic lateral sclerosis	8.17e-06	0.000153	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.17e-06	0.000153	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.16e-06	0.000153	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.85e-06	0.000147	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.81e-06	0.000146	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.71e-06	0.000145	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.6e-06	0.000142	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	7.57e-06	0.000142	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.53e-06	0.000141	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.5e-06	0.000141	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.45e-06	0.00014	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	7.36e-06	0.000138	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.32e-06	0.000137	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.22e-06	0.000135	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.19e-06	0.000135	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.15e-06	0.000134	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.08e-06	0.000133	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	6.99e-06	0.000131	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.97e-06	0.000131	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	6.77e-06	0.000127	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.72e-06	0.000126	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	6.72e-06	0.000126	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.57e-06	0.000123	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.51e-06	0.000122	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.49e-06	0.000122	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.41e-06	0.00012	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.36e-06	0.000119	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	6.17e-06	0.000116	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.13e-06	0.000115	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.97e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.97e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	5.94e-06	0.000111	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.84e-06	0.00011	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.74e-06	0.000108	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.63e-06	0.000106	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.61e-06	0.000105	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.6e-06	0.000105	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	5.4e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.39e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	5.36e-06	0.0001	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.24e-06	9.82e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.24e-06	9.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.16e-06	9.67e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.13e-06	9.62e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.12e-06	9.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.96e-06	9.3e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	4.91e-06	9.2e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.84e-06	9.07e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.81e-06	9.03e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.71e-06	8.84e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.7e-06	8.82e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.62e-06	8.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.6e-06	8.63e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.45e-06	8.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.43e-06	8.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.43e-06	8.3e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.23e-06	7.92e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.2e-06	7.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.08e-06	7.64e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.07e-06	7.63e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	3.96e-06	7.43e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.96e-06	7.42e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	3.88e-06	7.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	3.87e-06	7.26e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.86e-06	7.24e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.81e-06	7.15e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.7e-06	6.94e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.67e-06	6.88e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.66e-06	6.86e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.64e-06	6.83e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.64e-06	6.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.61e-06	6.77e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.59e-06	6.73e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.55e-06	6.66e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.36e-06	6.31e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	3.35e-06	6.29e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.35e-06	6.27e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.32e-06	6.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.08e-06	5.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	2.99e-06	5.61e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.94e-06	5.51e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.92e-06	5.48e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.83e-06	5.31e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.77e-06	5.2e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.75e-06	5.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.73e-06	5.12e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.71e-06	5.09e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.66e-06	4.98e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.65e-06	4.97e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.51e-06	4.7e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.49e-06	4.67e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.38e-06	4.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.33e-06	4.37e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.3e-06	4.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.19e-06	4.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.05e-06	3.85e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2e-06	3.75e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.89e-06	3.54e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.88e-06	3.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.87e-06	3.51e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.8e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.6e-06	3e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.23e-06	2.31e-05	CbGpPWpGaD
